Infectious Disorders - Drug Targets
Formerly: Current Drug Targets - Infectious Disorders
Volume 22, 8 Issues, 2022
ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)
This journal supports open access
ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)
This journal supports open access
Aims & Scope
Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews/mini-reviews and research articles written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development. All aspects related to viral or bacterial diseases including HIV, AIDS and other sexually transmitted diseases (STDs) are also included in the scope of the journal.
Infectious Disorders - Drug Targets
,Volume 22
-Number 2
Editorial
Shared Food, Meals and Drinks: 10 Arguments Suggesting an Oral Transmission Route of SARS-CoV-2
, 22(2): e160721194830Jean-Michel Wendling*, Aure Saulnier and Jean-Marc Sabatier
DOI: 10.2174/1871526521666210716110603
Editorial
Counter-Regulatory Renin-Angiotensin System: An Important Line of Research to Understand and Limit the Severity of COVID-19
, 22(2): e100921196331Cédric Annweiler*, Zhijian Cao, Nicolas Papon, Hervé Kovacic and Jean-Marc Sabatier
DOI: 10.2174/1871526521666210910063227
Letter to the Editor
COVID-19 and Infectious Disease Speciality - A Necessity of Time in India
, 22(2): e170322191976Gopal K. Bohra, Deepak Kumar* and Mahendra K. Garg
DOI: 10.2174/1871526521666210302155650
Letter to the Editor
DAMPening Severe COVID-19 with Dexamethasone
, 22(2): e270821195910Cédric Annweiler*, Nicolas Papon, Jean-Marc Sabatier and Jean Barré
DOI: 10.2174/1871526521999210827142839
Review Article (Mini-Review)
A Mini Review on the Pathogenesis, Diagnosis and Treatment Options for COVID-19
, 22(2): e170322191922Farzad Rahmani, Aghigh Ziaeemehr, Sajede Alijannejad, Gordon A Ferns, Majid Khazaei, Soodabeh Shahidsales* and Amir Avan*
DOI: 10.2174/1871526521666210301142223
Review Article
Prevention of Vancomycin-Induced Nephrotoxicity; An Updated Review of Clinical and Preclinical Studies
, 22(2): e310321192584Hamid Rahmani and Hossein Khalili*
DOI: 10.2174/1871526521666210331164552
Review Article
Interaction of Host Pattern Recognition Receptors (PRRs) with Mycobacterium Tuberculosis and Ayurvedic Management of Tuberculosis: A Systemic Approach
, 22(2): e130921196420Nirmaladevi Ponnusamy and Mohanapriya Arumugam*
DOI: 10.2174/1871526521666210913110834
Review Article
Skin Diseases and their Treatment Strategies in Sub-Saharan African Regions
, 22(2): e270921196808Esra Tariq Anwar, Nandan Gupta, Omji Porwal*, Akanksha Sharma, Rishabha Malviya*, Amit Singh and Neeraj Kumar Fuloria
DOI: 10.2174/1871526521666210927120334
Infectious Disorders - Drug Targets, Volume 22 (2022) - Number 4
This issue is in progress but contains articles that are final and fully citable.
Infectious Disorders - Drug Targets, Volume 22 (2022) - Number 3
This issue is in progress but contains articles that are final and fully citable.
Articles Ahead of Print
Hydroxychloroquine (HCQ) Treatment for Hospitalized Patients with COVID- 19
Hristina Tsanovska, Iana Simova, Vladislav Genov, Todor Kundurzhiev, Jordan Krasnaliev, Vladimir Kornovski, Nikolai Dimitrov and Toni Vekov
DOI: 10.2174/1871526522666220303121209
View Abstract View on PubMed
Appropriate Use of Antibiotics for the Management of Respiratory Tract Infections
Himanshu Raghav, Prachi Tayal, Rina Das and Dinesh Kumar Mehta*
DOI: 10.2174/1871526522666220118122516
View Abstract View on PubMed
Helicobacter pylori Coccoid Forms as a Possible Target of Eradication Therapy
Nikita Gladyshev, Maria Taame and Viacheslav Kravtsov*
DOI: 10.2174/1871526522666220318110705
View on PubMed
Deciphering the Significance of Plasma Chemokines as Prognostic Biomarkers in Pegylated IFN-Î-2a /Ribavirin-Treated Chronic Hepatitis C Genotype 4 Patients
M. Haroon Hamed, Peter Natesan Pushparaj, Shafiqur Rehman, Saleh Al-Karim, Salem Bazarah and Ishtiaq Qadri*
DOI: 10.2174/1871526522666220303142837
View Abstract View on PubMed
Impact of Tocilizumab on Inflammatory Markers and Oxygen Status in Severe COVID-19 Patients: A Single Centre Retrospective Study
Abhishek Sharma, Deepak Nathiya, Supriya Suman, Hemant Bareth, Mahaveer Singh* and Eshan Sharma
DOI: 10.2174/1871526522666220221143920
View Abstract View on PubMed
A Case of Toxoplasma gondii and Strongyloides stercoralis Coinfection in an Immunocompromised Patient
Saumya Srivastava, Aditya Kundu, Haripriya Sivakumar, Vibhor Tak*, Durga Shankar Meena, Subhashree Samantray and Deepak Kumar
DOI: 10.2174/1871526522666220218114426
View Abstract View on PubMed
COVID-19 Infection in Pregnancy: A Review
Sabrina Jahan Mily, Kazi Mahmuda Akter, Nowshin Jabin, Saikat Mitra, Talha Bin Emran, Monisha Nandi, Sumit Kumar Baral, Md. Zia Uddin, Jewel Mallick, Arkajyoti Paul, Syed Uzair Ali Shah, Abdur Rauf, Ishaq N. Khan and Mohammad S. Mubarak*
DOI: 10.2174/1871526522666220105111358
View Abstract View on PubMed
SARS-CoV-2-Induced Neurological Disorders in Symptomatic Covid-19 and Long Covid Patients: Key Role of Brain Renin-Angiotensin System
Ziad Fajloun*, Hervé Kovacic, Cédric Annweiler, Yingliang Wu, Zhijian Cao and Jean-Marc Sabatier*
DOI: 10.2174/1871526522666220406124618
View on PubMed
Prevalence, Presentation and Outcome of Secondary Bloodstream Infections among COVID-19 Patients
Subhashree Samantaray, Priyabrat Karan, Anuradha Sharma*, Vijayalakshmi Nag, Naveen Dutt, Mahendra Kumar Garg, Pradeep Kumar Bhatia and Sanjeev Misra
DOI: 10.2174/1871526522666220418093450
View Abstract View on PubMed
Abstracts Ahead of Print
Sagacious perceptive on Marburg virus foregrounding the recent findings :A Critical Review
Bilha Baby, Rajalakshmi R, Manju M Nair and Roshni P R*
DOI: 10.2174/1871526522666220510103618
View Abstract
Native Iranian Medicinal Plants with Anti-Vaginal Infection Properties: A Systematic Review
Marzieh Rashidipour, Pegah Shakib*, Gholamreza Goudarzi, Yadollah Pournia, Maryam Karimi and Maryam Sarlak
DOI: 10.2174/1871526522666220501171551
View Abstract
Demographic, clinical, investigational characteristics of COVID-19 related Guillain-Barré syndrome with differences from typical and another virus-related Guillain-Barré syndrome
Jitendra Singh, Nilesh Kumar and Anju Dinkar*
DOI: 10.2174/1871526522666220429134113
View Abstract
âConvalescent Plasmaâ- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review
Sumel Ashique*, Tahamina Khatun, Garima Sahu, Aakash Upadhyay, Archana Adhana, Nitish Kumar, Shubneesh Kumar and Navjot Sandhu
DOI: 10.2174/1871526522666220425103031
View Abstract
The emergence of Omicron SARS-CoV-2 variant (B.1.1.529) - the latest episode in the COVID-19 pandemic with a global riposte
Suman Kumar Ray and Sukhes Mukherjee*
DOI: 10.2174/1871526522666220422110415
View Abstract
Infection and Severity of COVID-19 infection among health care workers: A report from Egypt
Ehab F Moustafa, Sahar M Hassany, Asmaa Mohamed Ahmed Soliman, Mohammed Ezz-Eldin, Nariman Zaghloul and Sherief Abd-Elsalam*
DOI: 10.2174/1871526522666220422105740
View Abstract
Epigenetic-related effects of COVID-19 on the human cells
Arezoo Faramarzi, Reza Safaralizadeh*, Narges Dastmalchi and Shahram Teimourian
DOI: 10.2174/1871526522666220420093029
View Abstract
Recent Discoveries Of Nitrogen-Containing Heterocyclic Compounds as InhA Inhibitors Against Mycobacterium Tuberculosis: An Overview
Pratibha D. Gupta, Kalpana N. Tilekar, Neha M. Upadhyay and Ramaa C. S.*
DOI: 10.2174/1871526522666220420092618
View Abstract
COVID-19 vaccination, Peltzman Effect and possible increase in high-risk behaviors: a growing concern on risk compensation and reduced compliance to Public Health protective Measures after vaccines rollout
Shahab Falahi, Jasem Mohamadi, Hojjat Sayyadi, Iraj Pakzad, Ayoub Rashidi, Razi Naserifar, Jahangir Abdi and Azra Kenarkoohi*
DOI: 10.2174/1871526522666220419133849
View Abstract
Acute lung injury with Amphotericin infusion in a patient with Invasive Mucormycosis
Swapnil Tripathi, Durga Shankar Meena*, Deepak Kumar and Gopal Krishana Bohra
DOI: 10.2174/1871526522666220419132741
View Abstract
Published Contents
Editor's Choice
Transmission Modes of COVID-19: A Systematic Review
, 2021; 21(6): 6 - 13Esmaeil Mehraeen, Mohammad Amin Salehi, Farzane Behnezhad, Hamed Rezakhani Moghaddam and SeyedAhmad SeyedAlinaghi*
DOI: 10.2174/1871526520666201116095934
Seroprevalence of Hepatitis E Virus Infection Among Pregnant Women in Ilam, West of Iran
, 2021; 21(5): 14 - 17Azra Kenarkoohi, Shahab Falahi, Fariba ghelijie and Asad Mirzaei*
DOI: 10.2174/1871526520999201103193321
Ocular COVID-19: Eyes as a Reservoir to Conceal and Spread SARSCoV- 2
, 2021; 21(4): 480 - 483Abdul Mannan Baig*, Saara Ahmad, Areeba Khaleeq, Hamna Rafique, Shafiqa Rajput, Mehaer Angez, Ayesha Hameed, Talha Nawaz and Preet Katyara
DOI: 10.2174/1871526520999200729182242
Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report
, 2021; 21(3): 468 - 472Zahra Ahmadinejad, Faeze Salahshour, Omid Dadras, Hesan Rezaei and SeyedAhmad SeyedAlinaghi*
DOI: 10.2174/1871526520666200609125045
Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-associated Pneumonia Caused by Multidrugresistant Bacteria: A Randomized, Single-blind Clinical Trial
, 2021; 21(2): 274 - 283Mahila Monajati, Shahram Ala*, Masoud Aliyali, Roya Ghasemian, Fatemeh Heidari, Mohammad Ahanjan, Siavash Moradi, Ali Sharifpour, Mojtaba Mojtahedzadeh and Ebrahim Salehifar
DOI: 10.2174/1871526520666200227102013
Monoclonal Antibodies Against Infectious Microbes: So Long and Too Little!
, 2021; 21(1): 4 - 27Gerard M. Raj*, Rekha Priyadarshini, Sakthibalan Murugesan and Mangaiarkkarasi Adhimoolam
DOI: 10.2174/1871526520666200312154649
The In Vitro Study of Anti-leishmanial Effect of Naja naja oxiana Snake Venom on Leishmania major
, 2020; 20(6): 913 - 919Nastaran Fallahi, Delavar Shahbazzadeh, Fatemeh Maleki, Marjaneh Aghdasi, Fatemeh Tabatabaie* and Khadijeh Khanaliha*
DOI: 10.2174/1871526520666200106121839
Detection of Virulence Factors and Antibiotic Resistance Pattern of Clinical and Intensive Care Unit Environmental Isolates of Pseudomonas aeruginosa
, 2020; 20(5): 758 - 762Omid Zarei, Hassan Mahmoudi, Ali Mohammadi Bardbari, Pezhman Karami and Mohammad Yousef Alikhani*
DOI: 10.2174/1871526520666191231124717
Clinical and Epidemiologic Features of Visceral Leishmaniasis in Children: A 6-year Study from an Iranian Referral Hospital
, 2020; 20(4): 461 - 466Mohamadreza Abdolsalehi, Babak Pourakbari, Shima Mahmoudi, Mina Moradzadeh, Hossein Keshavarz and Setareh Mamishi*
DOI: 10.2174/1871526519666190613123217
A Brief History of Ebolavirus Disease: Paving the Way Forward by Learning from the Previous Outbreaks
, 2020; 20(3): 259 - 266Meryem Jefferies, Harunor Rashid, Grant A. Hill-Cawthorne and Veysel Kayser*
DOI: 10.2174/1871526518666181001125106
Open Access Articles
Enhancing the Alternative Cellular Energy (ACE) Pathway with KELEA Activated Water as Therapy for Infectious Diseases
, 2021; 21(3): 314 - 319W. John Martin*
PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?
, 2019; 19(4): 337 - 349Raphael Taiwo Aruleba*, Tayo Alex Adekiya, Babatunji Emmanuel Oyinloye, Priscilla Masamba, Londiwe Simphiwe Mbatha, Ashley Pretorius and Abidemi Paul Kappo
Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia
, 2017; 17(1): 14 - 23Mogahid M. Elhassan, Hassan A. Hemeg, Miskelyemen A. Elmekki, Khalid A. Turkistani and Ahmed A. Abdul-Aziz
Most Cited Articles
Review Article
A review on free radicals and antioxidants
, 2020; 20(1): 16-26.Hourieh Alkadi*
DOI: 10.2174/1871526518666180628124323
Editorial
Counter-regulatory ‘renin-angiotensin’ system-based candidate drugs to treat COVID-19 diseases in SARS-CoV-2-infected patients
, 2020; 20(4): 407-408.Cédric ANNWEILER, Zhijian CAO, Yingliang WU, Emmanuelle FAUCON, Stéphanie MOUHAT, Hervé KOVACIC and Jean-Marc SABATIER
DOI: 10.2174/1871526520666200518073329
Case Report
A patient with COVID-19 disease in a referral hospital in Iran: A typical case
, 2020; 20(4): 559-562.Fereshteh Ghiasvand, Sepideh Zahak Miandoab, Hamid Harandi, Fereshteh Shahmari Golestan and Seyed Ahmad Seyed Alinaghi*
DOI: 10.2174/1871526520666200429115535
Review Article
SARS-CoV-2: The path of prevention and control
, 2021; 21(3): 358-362.Amal A. Mohamed, Nouran Mohamed, Seham Mohamoud, Fawkia E. Zahran, Rania Abdelmonem Khattab, Dalia Ali El-Damasy, Eman Alsayed and Sherief Abd-Elsalam*
DOI: 10.2174/1871526520666200520112848
Letter to the Editor
A viewpoint on angiotensin-converting enzyme 2, anti-hypertensives and coronavirus disease 2019 (COVID-19)
, 2021; 21(3): 311-313.Suraj N. Mali*, Bapu R. Thorat and Atul R. Chopade
DOI: 10.2174/1871526520666200511005546
Editorial
SARS-CoV-2 & COVID-19: Key-roles of the ‘renin-angiotensin’ system vitamin d impacting drug and vaccine developments
, 2020; 20(3): 348-349.Zhijian Cao, Yingliang Wu, Emmanuelle Faucon and Jean-Marc Sabatier
DOI: 10.2174/1871526520999200505174704
Review Article
Albendazole and treatment of hydatid cyst: Review of the literature
, 2019; 19(2): 101-104.Azar B. Dehkordi, Behnam Sanei, Morteza Yousefi, Seyedeh M. Sharafi, Farhang Safarnezhad, Rasool Jafari and Hossein Y. Darani*
DOI: 10.2174/1871526518666180629134511
Review Article
Repurposing of existing statin drugs for treatment of microbial infections: How much promising?
, 2019; 19(3): 224-237.Ritika Rana, Ruchika Sharma and Anoop Kumar*
DOI: 10.2174/1871526518666180806123230
Review Article
Hepatitis C virus: Efficacy of new daas regimens
, 2020; 20(2): 143-149.Amal Ahmed Mohamed, Naglaa El-Toukhy Ramadan El-Toukhy, Ebada Mohamed Said, Hoda Mohamed Rabie Gabal, Hossameldin AbdelAziz, Wahid Doss, Hadeel El-Hanafi, Hala H. El Deeb, Seham Mahmoud, Mahmoud Elkadeem, Hassan Salama Shalby and Sherief Abd-Elsalam*
DOI: 10.2174/1871526519666190121114003
Systematic Review Article
Efficacy of lopinavir/ritonavir compared with standard care for treatment of coronavirus disease 2019 (COVID-19): A systematic review
, August 2021; 21(5): 8-17.Timotius Ivan Hariyanto, Elizabeth Kristine, Catherine Jillian Hardi and Andree Kurniawan*
DOI: 10.2174/1871526520666201029125725
Review Article
PZQ therapy: How close are we in the development of effective alternative anti-schistosomal drugs?
, 2019; 19(4): 337-349.Raphael Taiwo Aruleba*, Tayo Alex Adekiya, Babatunji Emmanuel Oyinloye, Priscilla Masamba, Londiwe Simphiwe Mbatha, Ashley Pretorius and Abidemi Paul Kappo
DOI: 10.2174/1871526519666181231153139
Research Article
Synthesis, biological evaluation and molecular docking studies of new pyrazolines as an antitubercular and cytotoxic agents
, 2019; 19(3): 310-321.Bontha Venkata Subrahmanya Lokesh*, Y. Rajendra Prasad and Afzal Basha Shaik
DOI: 10.2174/1871526519666181217120626
Review Article
Antiviral drugs and acute kidney injury (AKI)
, 2019; 19(4): 375-382.Wattana Leowattana *
DOI: 10.2174/1871526519666190617154137
Research Article
High-level aminoglycoside resistance in enterococcus faecalis and enterococcus faecium; as a serious threat in hospitals
, 2020; 20(2): 223-228.Mahmoud Khodabandeh, Mohsen Mohammadi , Mohammad Reza Abdolsalehi, Meysam Hasannejad-Bibalan , Mehrdad Gholami , Azadeh Alvandimanesh, Abazar Pournajaf and Ramazan Rajabnia*
DOI: 10.2174/1871526519666181130095954
Research Article
Sofosbuvir, pegylated interferon and ribavirin in the treatment of an Egyptian cohort with hepatitis C virus infection in real-life clinical practice
, 2019; 19(2): 179-184.Sherief Abd-Elsalam*, Rehab Badawi, Sally Elnawasany, Mohamed Yousef, Loai Mansour, Nehad Hawash, Reham A. Elkhouly, Shaimaa Soliman, Amal Selim, Abdelrahman Kobtan and Asem Elfert
DOI: 10.2174/1871526518666180912121835
Most Accessed Articles
A Review on Free Radicals and Antioxidants
, 2020; 20(1): 16-26.Alkadi, Hourieh
DOI: 10.2174/1871526518666180628124323
Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients
, 2020; 20(4): 407-408.Annweiler, Cédric; Cao, Zhijian; Wu, Yingliang; Faucon, Emmanuelle; Mouhat, Stéphanie; Kovacic, Hervé; Sabatier, Jean-Marc
DOI: 10.2174/1871526520666200518073329
SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments
, 2020; 20(3): 348-349.Cao, Zhijian; Wu, Yingliang; Faucon, Emmanuelle; Sabatier, Jean-Marc
DOI: 10.2174/1871526520999200505174704
SARS-CoV-2: The Path of Prevention and Control
, 2021; 21(3): 358-362.Mohamed, Amal A.; Mohamed, Nouran; Mohamoud, Seham; Zahran, Fawkia E.; Khattab, Rania Abdelmonem; El-damasy, Dalia Ali; Alsayed, Eman; Abd-Elsalam, Sherief
DOI: 10.2174/1871526520666200520112848
A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19)
, 2021; 21(3): 311-313.Mali, Suraj N.; Thorat, Bapu R.; Chopade, Atul R.
DOI: 10.2174/1871526520666200511005546
High-Level Aminoglycoside Resistance in Enterococcus Faecalis and Enterococcus Faecium; as a Serious Threat in Hospitals
, 2020; 20(2): 223-228.Khodabandeh, Mahmoud; Mohammadi, Mohsen; Abdolsalehi, Mohammad Reza; Hasannejad-Bibalan, Meysam; Gholami, Mehrdad; Alvandimanesh, Azadeh; Pournajaf, Abazar; Rajabnia, Ramazan
DOI: 10.2174/1871526519666181130095954
Hepatitis C Virus: Efficacy of New DAAs Regimens
, 2020; 20(2): 143-149.Mohamed, Amal Ahmed; El-Toukhy, Naglaa El-Toukhy Ramadan; Said, Ebada Mohamed; Gabal, Hoda Mohamed Rabie; AbdelAziz, Hossameldin; Doss, Wahid; El-Hanafi, Hadeel; Deeb, Hala H. El; Mahmoud, Seham; Elkadeem, Mahmoud; Shalby, Hassan Salama; Abd-Elsalam, Sherief
DOI: 10.2174/1871526519666190121114003
Repurposing of Existing Drugs for the Bacterial Infections: An In silico and In vitro Study
, 2020; 20(2): 182-197.Kapoor, Yachika; Sharma, Ruchika; Kumar, Anoop
DOI: 10.2174/1871526519666181126094244
Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
, 2021; 21(4): 541-552.Akhtar, Nahid; Joshi, Amit; Singh, Bhupender; Kaushik, Vikas
DOI: 10.2174/1871526520666200921154149
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
, 2021; 21(4): 608-618.Chowdhury, Trinath; Roymahapatra, Gourisankar; Mandal, Santi M
DOI: 10.2174/1871526520666200727153643
A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case
, 2020; 20(4): 559-562.Ghiasvand, Fereshteh; Miandoab, Sepideh Zahak; Harandi, Hamid; Golestan, Fereshteh Shahmari; SeyedAlinaghi, SeyedAhmad
DOI: 10.2174/1871526520666200429115535
Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison
, 2020; 20(6): 778-783.Farhoudi, Behnam; SeyedAlinaghi, SeyedAhmad; Ataeinia, Bahar; Hosseini, Mostafa; Jafari, Sirous; Alasvand, Ramin; Tashakoriyan, Mehrzad; Mohraz, Minoo
DOI: 10.2174/1871526519666191015151639
Pharmaco-Audiology Vigilance in the Treatment of Adult Patients with HIV/Aids: Ototoxicity Monitoring Protocol Recommendation
, 2020; 20(1): 33-42.Khoza-Shangase, Katijah
DOI: 10.2174/1871526518666181016102102
Hand Hygiene Compliance and Effectiveness Against Respiratory Infections Among Hajj Pilgrims: A Systematic Review.
, 2020; 20(3): 273-283.Alqahtani, Amani S; Fakeerh, Mutaz; Bondagji, Daniah; Park, Silvia; Heywood, Anita E; Wiley, Kerrie E; Booy, Robert; Rashid, Harunor
DOI: 10.2174/1871526518666181001145041
Chloroquine as Chemoprophylaxis for COVID-19: Will This Work.
, 2021; 21(4): 473-474.Abd-Elsalam, Sherief; Elkadeem, Mahmoud; Glal, Khadija Ahmed
DOI: 10.2174/1871526520666200726224802
Editor-in-Chief
Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
(France)
Biography
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
Biography
Biography of Jean-Marc Sabatier
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets - Infectious Disorders was launched in 2001 and later renamed in 2006 as Infectious Disorders - Drug Targets.
Webmaster Contact: info@benthamscience.net